Relmada Therapeutics (RLMD) Interest Coverage Ratio (QoQ) (2012 - 2026)
Relmada Therapeutics (RLMD) Interest Coverage Ratio (QoQ) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Relmada Therapeutics | 205.29 Mn | 205.29 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 99.94% |
| Mar 31, 2025 | 43.94% |
| Dec 31, 2024 | -1,676.59% |
| Sep 30, 2024 | 28.25% |
| Jun 30, 2024 | -3,421.65% |
| Mar 31, 2024 | 99.87% |
| Dec 31, 2023 | -102.01% |
| Sep 30, 2023 | 6.83% |
| Jun 30, 2023 | 7.78% |
| Mar 31, 2023 | -652.64% |
| Sep 30, 2020 | -234.70% |
| Jun 30, 2020 | 805.41% |
| Mar 31, 2020 | -53.55% |
| Dec 31, 2019 | 46.80% |
| Sep 30, 2019 | 1.96% |
| Jun 30, 2019 | -149.23% |
| Mar 31, 2019 | -197.15% |
| Dec 31, 2018 | 139.95% |
| Mar 31, 2018 | 53.28% |
| Dec 31, 2017 | -1,704.93% |